A review of current therapeutics targeting the mitochondrial protease ClpP in diffuse midline glioma, H3 K27-altered.
- DOI
- 10.1093/neuonc/noad144
- Published
- 2024 May 3
- Container
- Neuro-oncology
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1093/neuonc/noad144,
title = {A review of current therapeutics targeting the mitochondrial protease ClpP in diffuse midline glioma, H3 K27-altered.},
author = {Jackson ER and Persson ML and Fish CJ and Findlay IJ and Mueller S and Nazarian J and Hulleman E and van der Lugt J and Duchatel RJ and Dun MD},
year = {2024},
journal = {Neuro-oncology},
doi = {10.1093/neuonc/noad144},
url = {https://doi.org/10.1093/neuonc/noad144}
}RIS
TY - JOUR TI - A review of current therapeutics targeting the mitochondrial protease ClpP in diffuse midline glioma, H3 K27-altered. AU - Jackson ER AU - Persson ML AU - Fish CJ AU - Findlay IJ AU - Mueller S AU - Nazarian J AU - Hulleman E AU - van der Lugt J AU - Duchatel RJ AU - Dun MD PY - 2024 JO - Neuro-oncology DO - 10.1093/neuonc/noad144 UR - https://doi.org/10.1093/neuonc/noad144 ER -
APA
ER, J., ML, P., CJ, F., IJ, F., S, M., J, N., E, H., J, V. D. L., RJ, D., & MD, D. (2024). A review of current therapeutics targeting the mitochondrial protease ClpP in diffuse midline glioma, H3 K27-altered.. Neuro-oncology. https://doi.org/10.1093/neuonc/noad144
Source records
- pubmed · retrieved 2026-09-26T05:09:33.944Z